– Recipients include 20 individuals living with Duchenne muscular dystrophy and five siblings of individuals living with Duchenne

CAMBRIDGE, Mass., September 05, 2024--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced 25 recipients of Route 79, The Duchenne Scholarship Program for the 2024-2025 academic year. Of the academic scholarships, 20 will be awarded to individuals living with Duchenne muscular dystrophy and five to siblings of individuals living with Duchenne. Each recipient will receive a scholarship of up to $5,000.

"On behalf of Sarepta and the selection committee, we are thrilled to announce the recipients of Route 79, The Duchenne Scholarship Program for the 2024-2025 academic year. From small private colleges to some of the largest research universities in the world, this class of recipients were impressive for their academic success, profound curiosity, commitment to learning and fierce determination," said Diane Berry, Ph.D., executive vice president and Chief Global Policy & Advocacy Officer, Sarepta. "Over the past seven years, Sarepta has awarded nearly 140 scholarships through the Route 79 program. We are honored to support the growth of these young adults as they begin the next chapter of their academic journey."

The Route 79 program was created in 2018 to recognize exceptional individuals living with Duchenne as they pursue their post-secondary education. In 2022, Sarepta expanded the program to include siblings of individuals with Duchenne in recognition of the impact that a diagnosis of Duchenne may have on the entire family. Recipients of the scholarship are chosen by an independent selection committee composed of Duchenne community members, who consider each applicant’s community involvement, academic achievements, and personal essay. In addition to application review by the independent committee, submissions are de-identified for the selection committee with no indication of whether the candidate has received, or plans to receive, a Sarepta therapy.

2024-2025 Route 79 Scholarship Recipients

• John "Jack" Becker, Embry-Riddle Aeronautical University, Daytona Beach

• Jacob Colby, The Evergreen State College

• Kyle Cox, Texas A&M University

• Bradon Coy, University of Florida

• John Herzfeld, Arizona State University, Downtown Phoenix

• Declan Hickey, Curry College

• Elliott Johnson, Lebanon Valley College

• Henry Johnson, Temple University

• Ryan Lugo, State University of New York at New Paltz

• John McConnell, Boise State University

• Josh Pflueger, Texas Christian University

• Ryan Schultz, Rowan University

• Jasdeep Singh, Cleveland Institute of Art

• Parker Strobeck, North Arkansas College

• Robert Sullivan, John Carroll University

• William Sun, University of California, Davis

• Braden Van Eperen, Union College

• Connor Vassigh, Lone Star College System

• Max Vertin, Hastings College

• Jack Wolf, University of Dayton